SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
+22.43%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.61B
AUM Growth
+$337M
(+26%)
Cap. Flow
+$88.6M
Cap. Flow
% of AUM
5.49%
Top 10 Holdings %
Top 10 Hldgs %
65.91%
Holding
83
New
16
Increased
18
Reduced
12
Closed
15
Top Buys
| 1 |
AstraZeneca
AZN
|
$42.1M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$15.6M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$13.6M |
| 4 |
Amgen
AMGN
|
$12.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$11M |
Top Sells
| 1 |
NextCure
NXTC
|
$23.5M |
| 2 |
Eli Lilly
LLY
|
$17.8M |
| 3 |
Merck
MRK
|
$15.8M |
| 4 |
Insmed
INSM
|
$10.2M |
| 5 |
TG Therapeutics
TGTX
|
$9.62M |
Sector Composition
| 1 | Healthcare | 95.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cytokinetics
CYTK
$5.95B
| $10.6M | 0.63% |
508,394
+159,098
| +46% | +$3.31M |
|
27
MacroGenics
MGNX
$123M
| $10.5M | 0.62% |
+458,807
| New | +$10.5M |
|
|
TCRR
28
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $10.3M | 0.61% |
333,707
+160,679
| +93% | +$4.97M |
|
|
29
Insmed
INSM
$30.1B
| $10.3M | 0.61% |
309,662
-305,481
| -50% | -$10.2M |
|
|
OBSV
30
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $9.88M | 0.59% |
4,749,623
| – | – |
|
|
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $9.33M | 0.56% |
121,373
+33,223
| +38% | +$2.55M |
|
32
Sarepta Therapeutics
SRPT
$1.93B
| $8.84M | 0.53% |
+51,848
| New | +$8.84M |
|
33
Acadia Pharmaceuticals
ACAD
$4.3B
| $8.8M | 0.52% |
164,625
+115,629
| +236% | +$6.18M |
|
34
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8.37M | 0.5% |
1,122,800
+329,746
| +42% | +$2.46M |
|
35
Syndax Pharmaceuticals
SNDX
$1.39B
| $8.29M | 0.49% |
+372,909
| New | +$8.29M |
|
36
Mirum Pharmaceuticals
MIRM
$3.73B
| $7.94M | 0.47% |
454,974
+133,722
| +42% | +$2.33M |
|
37
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $7.55M | 0.45% |
434,555
| – | – |
|
|
CCXI
38
DELISTED
ChemoCentryx, Inc.
CCXI
| $7.01M | 0.42% |
113,213
+31,978
| +39% | +$1.98M |
|
|
JNCE
39
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $6.48M | 0.39% |
+925,280
| New | +$6.48M |
|
40
Puma Biotechnology
PBYI
$257M
| $6.46M | 0.38% |
629,650
+153,668
| +32% | +$1.58M |
|
|
41
Eli Lilly
LLY
$666B
| $6.23M | 0.37% |
36,909
-105,523
| -74% | -$17.8M |
|
|
AMRN
42
Amarin Corp
AMRN
$311M
| $5.72M | 0.34% |
58,529
| – | – |
|
43
Aligos Therapeutics
ALGS
$74.7M
| $5.28M | 0.31% |
+7,642
| New | +$5.28M |
|
44
Arcus Biosciences
RCUS
$1.23B
| $4.84M | 0.29% |
+186,278
| New | +$4.84M |
|
|
XLRN
45
DELISTED
Acceleron Pharma Inc.
XLRN
| $4.69M | 0.28% |
36,688
-22,858
| -38% | -$2.92M |
|
|
APTO
46
DELISTED
Aptose Biosciences, Inc.
APTO
| $4.3M | 0.26% |
+2,180
| New | +$4.3M |
|
|
IGMS
47
DELISTED
IGM Biosciences
IGMS
| $3.99M | 0.24% |
+45,131
| New | +$3.99M |
|
48
Kura Oncology
KURA
$706M
| $3.94M | 0.23% |
120,677
-104,582
| -46% | -$3.42M |
|
|
49
TG Therapeutics
TGTX
$5.06B
| $3.41M | 0.2% |
65,474
-184,927
| -74% | -$9.62M |
|
|
MRNS
50
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.34M | 0.2% |
+274,027
| New | +$3.34M |
|